Jushi Holdings Announces Update on Expansion Project at Pennsylvania Grower-Processor Facility

Jushi Holdings Announces Update on Expansion Project at Pennsylvania Grower-Processor FacilityThe SAFE Banking Act is back in Congress, and political momentum is swinging in favor of the cannabis industry’s need to normalize its relations with financial institutions.Safe Harbor Services’ credit union banked $3 billion in cannabis funds last year, part of a vast but fairly under-the-radar ecosystem where businesses are building rapport with smaller independent financial institutions like regional credit unions. There’s a lot to know to make sure that it’s a productive relationship, and federal reform is only one piece of the puzzle. Much of the work falls to the cannabis business, of course.Here, we spoke with Safe Harbor Services Vice President Amanda McComb about some of the recent

Email Drip Series #3 – Moskowitz Report Full

Email Drip Series #3 - Moskowitz Report FullEmerging biotechs are researching once forbidden drugs to solve some of the most vexing medical problems...those of mental health.Major investors have launched this sector with over a half-billion dollars in start-up capitalization and they’re already seeing substantial returns!This trend is just getting started!Forbes reports that the emerging market in new psychoactive mental health medications... “could bring in a whopping $6.85 billion by 2027.”1We are Now Entering Phase Two of a Pharmaceutical RenaissanceResearch is mounting. An entirely new class of psychoactive medications is showing profound efficacy in treating mental disorders and traumatic brain injuries.This is cutting edge medical science that has been buried for decades by out-of-date taboos. But times are changing.Findings are that once-forbidden psycho-active

Why Dollar-Cost Averaging Makes Sense For Psychedelic Stocks

Why Dollar-Cost Averaging Makes Sense For Psychedelic Stocks Market conditions have never been more uncertain Investor behavior has never been more erratic Most price action is arbitrary – drive by entirely exogenous factors After a spectacular rise in 2020, investors in psychedelic stocks have been confronted with a much different scenario in early 2021.There is currently considerable turmoil in global markets. We’ve seen a general pullback in tech stocks and small caps. In the face of these market headwinds, psychedelic stocks have been steadily giving ground.Cheap stocks in turbulent marketsWe know these stocks are now objectively cheap.Over US$400 million has been added to the balance sheets of these public companies in recent months via new financings. Simultaneously, market caps for these companies have collectively

Study Shows Cannabinoids May Help With Pathological Tremors

Study Shows Cannabinoids May Help With Pathological Tremors A new study from the Department of Neuroscience at the Faculty of Health and Medical Sciences at the University of Copenhagen, published in Nature Neuroscience and titled “Spinal astroglial cannabinoid receptors

Australis Completes First Stage in Green Therapeutics LLC Acquisition

Australis Completes First Stage in Green Therapeutics LLC AcquisitionAustralis Capital Inc. (CSE: AUSA) (OTC: AUSAF) today announced that, further to the Company’s press releases of January 5, 2021 , and March 12, 2021 , it has completed the first stage of the transaction to acquire Green Therapeutics LLC. The transaction is being completed in two parts, the first, which has now closed, being the acquisition of a subsidiary of GT containing a number of unregulated assets including the GT brands and certain ancillary agreements including brand licensing and management agreements. Subsequently, subject to regulatory approval, the Company will complete the acquisition of GT itself. In conjunction with the completion of the acquisition of the Subsidiary, the parties have settled a previously

Is Canopy Growth Priming The Pump For Some Major M&A Activity?

Is Canopy Growth Priming The Pump For Some Major M&A Activity? Last week, Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced an important milestone as it relates to its balance sheet and entered into a credit agreement for a US$750 million (USD) senior secured term loan. Under the terms of the credit agreement, Canopy Growth can obtain up to an additional $500 million of incremental senior secured debt. The transaction further strengthens Canopy Growth’s balance sheet, provides additional capital to invest in high-return growth opportunities, and marks an important development as the management team works towards achieving a more efficient capital structure. Going forward, Canopy Growth expects King Street to continue to serve as its anchor debt investor. Through this relationship, the management